Enavate Sciences GP, LLC Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$176.5B

Holdings

6

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
IMNMIMMUNOME INC
4,768,583$44.3B25.12%
2
SIONSIONNA THERAPEUTICS INC
2,478,030$43.0B24.35%
3
ZBIOZENAS BIOPHARMA INC
3,761,359$36.4B20.65%
4
UPBUPSTREAM BIO INC
2,459,703$27.0B15.30%
5
CMPXCOMPASS THERAPEUTICS INC
7,788,150$20.2B11.47%
6
CAMPCAMP4 THERAPEUTICS CORP
3,785,802$5.5B3.11%